Kodiak Sciences Inc. (KOD)
NASDAQ: KOD · Real-Time Price · USD
40.08
-0.55 (-1.35%)
Apr 6, 2026, 1:14 PM EDT - Market open
Kodiak Sciences Market Cap
Kodiak Sciences has a market cap or net worth of $2.47 billion as of April 6, 2026. Its market cap has increased by 1,306.65% in one year.
Market Cap
2.47B
Enterprise Value
2.36B
1-Year Change
1,306.65%
Ranking
Category
Stock Price
$40.08
Market Cap Chart
Since October 4, 2018, Kodiak Sciences's market cap has increased from $357.63M to $2.47B, an increase of 591.78%. That is a compound annual growth rate of 29.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 2.51B | 44.74% |
| Dec 31, 2025 | 1.73B | 231.69% |
| Dec 31, 2024 | 522.39M | 228.65% |
| Dec 29, 2023 | 158.95M | -57.33% |
| Dec 30, 2022 | 372.50M | -91.44% |
| Dec 31, 2021 | 4.35B | -41.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 4, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oruka Therapeutics | 2.64B |
| Disc Medicine | 2.49B |
| Immunome | 2.47B |
| Beam Therapeutics | 2.45B |
| Ascentage Pharma Group International | 2.44B |
| Sarepta Therapeutics | 2.44B |
| Veradermics | 2.40B |
| Celldex Therapeutics | 2.39B |